Gates supports $1 billion technology fund despite questionable past investments

Gates Foundation Launches New Initiative

On Thursday, the Gates Foundation, alongside its partners, unveiled Next-Ladder Ventures, a new initiative aimed at enhancing resources for what they call “Frontline Workers.” The foundation plans to invest $1 billion over the next 15 years, focusing on a demographic that may come as a surprise to many.

The initiative aims to “catalyze thriving markets that can attract ongoing investment in tools to prevent critical life moments from hindering upward mobility,” according to the founding group.

Next-Ladder Ventures is targeting around a third of the U.S. population, which suggests a substantial reach. It’s a bit unclear exactly how they plan to engage over 90 million individuals or why professions like social workers and lawyers are being categorized as “frontline experts.”

Initially, they will collaborate with a tech group named Humanity, utilizing an AI called Claude to seek solutions tailored for these workers.

Elizabeth Kelly, the director of human benefit deployments, stated, “The heart of our mission is to ensure that AI serves humanity.” She expressed excitement about making a tangible impact through technology, emphasizing the importance of improving vital services for those most in need.

Ryan Rippel, previously with the Gates Foundation’s Economic Mobility Program, is set to lead Next-Ladder Ventures as CEO. He pointed out that new, practical paths are essential to better assist those in need.

This venture, while ambitious, may evoke skepticism due to some of Gates’ past investment choices. The Gates Foundation has been significantly involved in funding various efforts, including the Covid vaccine initiative during the pandemic. They partnered with Gavi, the Vaccine Alliance, and were active in the Alliance for Epidemic Preparedness Innovation.

Moreover, Gates has invested heavily in agriculture across Africa, notably acquiring 500,000 shares in Monsanto, valued around $23 million. This company is often criticized for its production of genetically modified seeds.